Quantcast
Last updated on April 16, 2014 at 17:34 EDT

Latest HIV/AIDS Stories

2013-09-23 08:29:56

Donor Disbursements In 2012 Totaled US$7.86 Billion WASHINGTON, Sept. 23, 2013 /PRNewswire-USNewswire/ -- As world leaders prepare to meet to review progress towards the Millennium Development Goals, a report from the Kaiser Family Foundation and the Joint United Nations Programme on HIV/AIDS (UNAIDS) evaluates international efforts to finance the response to the AIDS epidemic. The annual funding analysis finds donor governments disbursed US$7.86 billion toward the AIDS response in...

2013-09-18 15:36:38

Administered intravaginally, microsphere treatment reverses suppression of immunity and circumvents antibiotic resistance A new gonorrhea treatment, based on an anti-cancer therapy  developed by a Buffalo startup company, has successfully eliminated gonococcal infection from female mice and prevented reinfection, according to research published today by University at Buffalo scientists in the Journal of Infectious Diseases. Through TherapyX Inc., an early stage biotech company in...

2013-09-18 15:28:54

Physical, sexual and emotional abuse among young gay black men is a pervasive problem, yet there remains a lack of social services and resources available to help them, a Michigan State University scholar argues in a new study. The trauma they experience – often at a young age – is related to depression, substance abuse and high-risk sexual behavior, said Robin Lin Miller, professor of psychology. “Young black men who are gay and bisexual have few resources available to them that...

2013-09-18 13:28:52

An experimental vaccine against human cytomegalovirus (CMV) infection, which endangers the developing fetus, organ transplant recipients, patients with HIV and others who have a weakened immune system, proved safe and more effective than previous vaccines developed to prevent infection by the ubiquitous virus. The first-of-its-kind approach to preventing human CMV infection, developed by a team of scientists at UC Davis and the University of Alabama, Birmingham, induced broader...

2013-09-12 20:21:33

DENVER, Sept. 12, 2013 /PRNewswire/ -- ViiV Healthcare today announced initial results from the Phase IIIb/IV FLAMINGO (ING114915) study. This open-label study, for the first time, compared once-daily regimens containing 50mg dolutegravir with once-daily regimens containing a protease inhibitor (PI) (800mg darunavir boosted with 100mg ritonavir) in treatment-naive adults with HIV-1. Both treatment arms were administered with investigator-selected dual NRTIs. Non-inferiority was demonstrated...

2013-09-12 16:27:49

Sustained Reduction of Viral Load at or Below Limit of Detection during Treatment Interruption of Antiretroviral Therapy RICHMOND, Calif., Sept. 12, 2013 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today the presentation of new data from its ongoing Phase 2 clinical trial (SB-728-902 Cohort 5) to evaluate a single infusion of Sangamo's novel ZFP Therapeutic(®), SB-728-T, for the treatment of HIV/AIDS. The data demonstrate functional control of the virus at or below...

2013-09-11 23:01:39

The Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) is honored to announce that Secretary Hillary Rodham Clinton will be the recipient of the organization’s Global Impact Award. Washington, DC (PRWEB) September 11, 2013 The Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) is honored to announce that Secretary Hillary Rodham Clinton will be the recipient of the organization’s Global Impact Award. The presentation will be held on December 3, 2013, and will coincide with EGPAF’s...

Scientists Testing AIDS Vaccine On Primates
2013-09-11 19:20:16

Brett Smith for redOrbit.com – Your Universe Online A promising new AIDS vaccine being developed at Oregon Health & Science University has demonstrated the capacity to effectively remove all traces of an AIDS-causing virus from non-human primates, according to a newly published report in the journal Nature. The vaccine is being tested on a primate form of HIV, called simian immunodeficiency virus (SIV), which causes AIDS in monkeys. After working further to refine the vaccine,...

2013-09-10 04:21:00

"If You Want To Die Young, Just Keep Making Condom-Less Porn -- Or You Can Come Work In A Legal Brothel, And Live To A Ripe Old Age Using Condoms!" CARSON CITY, Nev., Sept. 10, 2013 /PRNewswire/ -- Bunny Ranch (www.BunnyRanch.com) brothel baron Dennis Hof has announced that he will pay $1000 cash to the first 100 porn stars that abandon their condom-less XXX careers, and instead work for his Nevada-based seven-brothel empire, where they have a legally-mandated "all...

2013-09-09 23:22:27

America's leading inventor service company, InventHelp, is submitting this client's invention, the Condom, to companies for review. Pittsburgh, PA (PRWEB) September 09, 2013 Sexual prophylactics are very important for having safe sex since they can help prevent the spread of diseases as well as unwanted pregnancies. However, ordinary condoms don't always inspire people to buy and use them. "I saw a need for a more attractive and amusing condom," said an inventor from...


Latest HIV/AIDS Reference Libraries

Journal of Acquired Immune Deficiency Syndromes
2012-05-16 12:01:26

The Journal of Acquired Immune Deficiency Syndromes is a peer-reviewed medical journal established in 1988 and is currently published by Lippincott Williams & Wilkins. The journal was renamed ‘Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology’ in 1995, and then returned to its original title in 1999. The journal was the official publication of the International Retrovirology Association until 2000. This journal covers aspects of research in HIV/AIDS, including...

AIDS
2012-05-07 07:38:24

AIDS is a peer-reviewed scientific journal published 18 times yearly by Lippincott Williams & Wilkins, London, UK. It was established in 1987 and is the official journal of the International AIDS Society. It covers all aspects of HIV and AIDS research, including basic science, clinical trials, epidemiology, and social science. As of May 2012, the editor-in-chief is Jay A. Levy. AIDS has been cited as the most read journal in its area of science and has the highest impact of all...

70_dd0fb65b7366091c1e0897e58f1798fa
2011-02-23 20:58:48

Simian immunodeficiency virus (SIV), also known as African Green Monkey virus, is a retrovirus able to infect at least 33 species of African primates. SIV has been present in monkeys and apes for at least 32,000 years, probably longer. Strains from two of these primate species have crossed the barriers into humans resulting in HIV-2 and HIV-1. Contraction involves contact with the blood of chimps that are often hunted for bushmeat in Africa. SIV infections appear in many cases to be...

0_336928514f8c16d00d00e956be85245d
2011-02-17 15:06:48

Kaposi's sarcoma-associated herpesvirus (KSHV) one of seven currently known human cancer virus, is also the eighth human herpesvirus. Kaposi's sarcoma, caused by the virus, is common in AIDS patients, primary effusion lymphoma, and some types of multicentric Castelman's disease. Moritz Kaposi discovered the blood vessel tumor, in 1872, which would eventually be names Kaposi's sarcoma. It was originally though that KS was of Jewish and Mediterranean origins until it was found to be common...

0_a4499f7c8759b5cbe79bad5eca319070
2011-01-26 14:08:59

Human immunodeficiency virus (HIV), a lentivirus, causes acquired immunodeficiency syndrome (AIDS) which is a condition in humans were the immune system begins to fail, leading to life-threatening opportunistic infections. Infection is transferred through bodily fluids where HIV is present as both free virus particles and within infected immune cells. The four most common routes of infection are unsafe sex, contaminated needles, breast milk, and transmission from an infected mother to her...

More Articles (5 articles) »